Dr. Michael L Grossbard MD
Hematologist-Oncologist | Hematology & Oncology
1000 10th Ave Fl 11 Suite 11c02 New York NY, 10019About
Dr. Michael Grossbard is a hematologist oncologist practicing in New York, NY. Dr. Grossbard specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Yale University 1986
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 1991
Internal MedicineAmerican Board of Internal MedicineABIM- 1989
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Hematologic malignancies.
- Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
- Treatment of multiple myeloma by antibody mediated immunotherapy and induction of
- Hematologic malignancies: selected abstracts and commentary.
- Hematologic malignancies.
- The expanding frontier of radioimmunotherapy of relapsed Non-hodgkin's lymphoma.
- Rituximab therapy of B-cell neoplasms.
- The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R.
- CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.
- Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): a highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas.
- Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.
- Alemtuzumab in B-cell chronic lymphocytic leukemia.
- Empowering targeted therapy: lessons from rituximab.
- Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1.
- Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
Treatments
- Aids-related Malignancies
- Hodgkin Disease (hd)
- Multiple Myeloma (mm)
- Acute Lymphocytic Leukemia (all)
- Non Hodgkin's Lymphoma (nhl)
- Lymphoma
- Chronic Lymphocytic Leukemia (cll)
- Leukemia
Fellowships
- Dana Farber Cancer Institute Medical Oncology 1991
Experience & Accolades
- Professor, Department of MedicineNYU Langone Medical Center
- Director, Hematologic Malignancies Clinical PgmNYU Langone Medical Center
Dr. Michael L Grossbard MD's Practice location
Dr. Michael L Grossbard MD's reviews
Write ReviewPatient Experience with Dr. Grossbard
Recommended Articles
- Woman Who Battled Lymphoma Three Times Starts Support Group
Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- 7-year-old with Lymphoma Joins and Inspires Lacrosse Team
Sports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
Nearby Providers
- Dr. Ahmed Sawas M.D.51 W 51ST ST NEW YORK NY 10019
- Dr. Etta B Frankel M.D.425 W 59th St New York NY 10019
- Dr. Donald S Colbourn MD51 W 51ST ST NEW YORK NY 10019
- Dr. Anupama Goel MD1000 10th Ave New York NY 10019
- Dr. Seth Cohen MD1000 10th Ave New York NY 10019
- Dr. Gabriel Albert Sara M.D.1000 10th Ave New York NY 10019